BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11438675)

  • 1. Chk2 activation dependence on Nbs1 after DNA damage.
    Buscemi G; Savio C; Zannini L; Miccichè F; Masnada D; Nakanishi M; Tauchi H; Komatsu K; Mizutani S; Khanna K; Chen P; Concannon P; Chessa L; Delia D
    Mol Cell Biol; 2001 Aug; 21(15):5214-22. PubMed ID: 11438675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage.
    Lee JH; Xu B; Lee CH; Ahn JY; Song MS; Lee H; Canman CE; Lee JS; Kastan MB; Lim DS
    Mol Cancer Res; 2003 Jul; 1(9):674-81. PubMed ID: 12861053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex.
    Stracker TH; Morales M; Couto SS; Hussein H; Petrini JH
    Nature; 2007 May; 447(7141):218-21. PubMed ID: 17429352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent roles for nibrin and Mre11-Rad50 in the activation and function of Atm.
    Cerosaletti K; Concannon P
    J Biol Chem; 2004 Sep; 279(37):38813-9. PubMed ID: 15234984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity.
    Zhou BB; Chaturvedi P; Spring K; Scott SP; Johanson RA; Mishra R; Mattern MR; Winkler JD; Khanna KK
    J Biol Chem; 2000 Apr; 275(14):10342-8. PubMed ID: 10744722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.
    Yazdi PT; Wang Y; Zhao S; Patel N; Lee EY; Qin J
    Genes Dev; 2002 Mar; 16(5):571-82. PubMed ID: 11877377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A murine model of Nijmegen breakage syndrome.
    Williams BR; Mirzoeva OK; Morgan WF; Lin J; Dunnick W; Petrini JH
    Curr Biol; 2002 Apr; 12(8):648-53. PubMed ID: 11967151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mismatch repair system is required for S-phase checkpoint activation.
    Brown KD; Rathi A; Kamath R; Beardsley DI; Zhan Q; Mannino JL; Baskaran R
    Nat Genet; 2003 Jan; 33(1):80-4. PubMed ID: 12447371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.
    Lim DS; Kim ST; Xu B; Maser RS; Lin J; Petrini JH; Kastan MB
    Nature; 2000 Apr; 404(6778):613-7. PubMed ID: 10766245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest.
    Girard PM; Riballo E; Begg AC; Waugh A; Jeggo PA
    Oncogene; 2002 Jun; 21(27):4191-9. PubMed ID: 12082606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
    Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
    Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.
    Krause DR; Jonnalagadda JC; Gatei MH; Sillje HH; Zhou BB; Nigg EA; Khanna K
    Oncogene; 2003 Sep; 22(38):5927-37. PubMed ID: 12955071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.
    Takemura H; Rao VA; Sordet O; Furuta T; Miao ZH; Meng L; Zhang H; Pommier Y
    J Biol Chem; 2006 Oct; 281(41):30814-23. PubMed ID: 16905549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere instability in a human tumor cell line expressing NBS1 with mutations at sites phosphorylated by ATM.
    Bai Y; Murnane JP
    Mol Cancer Res; 2003 Dec; 1(14):1058-69. PubMed ID: 14707289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase.
    Jin J; Ang XL; Ye X; Livingstone M; Harper JW
    J Biol Chem; 2008 Jul; 283(28):19322-8. PubMed ID: 18480045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways.
    Falck J; Petrini JH; Williams BR; Lukas J; Bartek J
    Nat Genet; 2002 Mar; 30(3):290-4. PubMed ID: 11850621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder.
    Delia D; Piane M; Buscemi G; Savio C; Palmeri S; Lulli P; Carlessi L; Fontanella E; Chessa L
    Hum Mol Genet; 2004 Sep; 13(18):2155-63. PubMed ID: 15269180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nibrin forkhead-associated domain and breast cancer C-terminal domain are both required for nuclear focus formation and phosphorylation.
    Cerosaletti KM; Concannon P
    J Biol Chem; 2003 Jun; 278(24):21944-51. PubMed ID: 12679336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutation at the Nbs1 Threonine 278 site does not affect mouse development, but compromises the Chk2 and Smc1 phosphorylation after DNA damage.
    Li T; Wang ZQ
    Mech Ageing Dev; 2011 Aug; 132(8-9):382-8. PubMed ID: 21664921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models.
    Difilippantonio S; Celeste A; Fernandez-Capetillo O; Chen HT; Reina San Martin B; Van Laethem F; Yang YP; Petukhova GV; Eckhaus M; Feigenbaum L; Manova K; Kruhlak M; Camerini-Otero RD; Sharan S; Nussenzweig M; Nussenzweig A
    Nat Cell Biol; 2005 Jul; 7(7):675-85. PubMed ID: 15965469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.